Literature DB >> 18497319

Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome.

Daijiro Abe1, Chiaki Nakaseko, Masahiro Takeuchi, Hiroaki Tanaka, Chikako Ohwada, Emiko Sakaida, Yusuke Takeda, Kayo Oda, Shinichi Ozawa, Naomi Shimizu, Shinichi Masuda, Ryuko Cho, Miki Nishimura, Sonoko Misawa, Satoshi Kuwabara, Yasushi Saito.   

Abstract

POEMS syndrome is a rare plasma cell disorder characterized by peripheral neuropathy, monoclonal gammopathy, and high levels of serum vascular endothelial growth factor, the pathogenesis of which remains unclear. A unique feature of this syndrome is that the proliferating monoclonal plasma cells are essentially lambda-restricted. Here we determined complete nucleotide sequences of monoclonal immunoglobulin lambda light chain (IGL) variable regions in 11 patients with POEMS syndrome. The V-region of the Ig lambda gene of all 11 patients was restricted to the V lambda 1 subfamily. Searching for homologies with IGL germlines revealed that 2 germlines, IGLV1-44*01 (9/11) and IGLV1-40*01 (2/10), were identified, with an average homology of 91.1%. The IGLJ3*02 gene was used in 11 of 11 re-arrangements with an average homology of 92.2%. These data suggest that the highly restricted use of IGL V lambda 1 germlines plays an important role in the pathogenesis of POEMS syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497319     DOI: 10.1182/blood-2007-12-126979

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Amyloidosis and POEMS syndrome.

Authors:  Cheng E Chee; Angela Dispenzieri; Morie A Gertz
Journal:  Expert Opin Pharmacother       Date:  2010-06       Impact factor: 3.889

2.  Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome.

Authors:  Sébastien Bender; Vincent Javaugue; Alexis Saintamand; Maria Victoria Ayala; Mehdi Alizadeh; Matthieu Filloux; Virginie Pascal; Nathalie Gachard; David Lavergne; Fabienne Auroy; Michel Cogné; Frank Bridoux; Christophe Sirac; Arnaud Jaccard
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

3.  Heavy metals intoxication in a patient with POEMS-like symptoms: a case report.

Authors:  Jun Hao; Shouxin Li; Yuxue Chen
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 4.  POEMS Syndrome: an Enigma.

Authors:  Rahma Warsame; Uday Yanamandra; Prashant Kapoor
Journal:  Curr Hematol Malig Rep       Date:  2017-04       Impact factor: 4.213

5.  POEMS syndrome - A case report revealing a complex evolving diagnosis.

Authors:  David N Gachoka; Gregory Prince
Journal:  Clin Case Rep       Date:  2014-10-06

6.  Transitional B Cells in Early Human B Cell Development - Time to Revisit the Paradigm?

Authors:  Victoria G Martin; Yu-Chang Bryan Wu; Catherine L Townsend; Grace H C Lu; Joselli Silva O'Hare; Alexander Mozeika; Anthonius C C Coolen; David Kipling; Franca Fraternali; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2016-12-02       Impact factor: 7.561

7.  Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study.

Authors:  Yong Wang; Li-Bo Huang; Yi-Hua Shi; Huan Fu; Zhen Xu; Guo-Qing Zheng; Yan Wang
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

8.  Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.

Authors:  Sho Ikeda; Takahiro Kobayashi; Masaya Saito; Atsushi Komatsuda; Kumi Ubukawa; Yoshihiro Kameoka; Naoto Takahashi
Journal:  Intern Med       Date:  2019-08-06       Impact factor: 1.271

Review 9.  POEMS SYNDROME: an Update.

Authors:  Andrea Nozza
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

10.  A case report of POEMS syndrome with renal involvement as immunotactoid glomerulopathy.

Authors:  Yan Wang; Yu Yan; Zhun Sui; Bao Dong; Li Zuo
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.